Evonik specifies outlook for 2016 following a good second quarter
- Evonik registered considerable volume growth in the first six months of 2016, mainly as a result of growth in the second quarter.
- Adjusted EBITDA margin continues at very good level of 18.1 percent in the first six months
- Adjusted net income above €500 million
- Outlook for the full year specified: Evonik still expects to report slightly lower sales in 2016 (2015: €13.5 billion) mainly due to declining selling prices. Adjusted EBITDA in the upper half of the anticipated range of €2.0 billion to €2.2 billion.
Exhibitor: Evonik Degussa (China) Co., Ltd.